AAAAAA

   
Results: 1-25 |
Results: 25
Radiosurgery for brain metastases from primary lung carcinoma
Authors: Hoffman, R Sneed, PK McDermott, MW Chang, S Lamborn, KR Park, E Wara, WM Larson, DA
Citation: R. Hoffman et al., Radiosurgery for brain metastases from primary lung carcinoma, CANCER J, 7(2), 2001, pp. 121-131
A hypoxia-regulated adeno-associated virus vector for cancer-specific genetherapy
Authors: Ruan, HJ Su, H Hu, L Lamborn, KR Kan, YW Deen, DF
Citation: Hj. Ruan et al., A hypoxia-regulated adeno-associated virus vector for cancer-specific genetherapy, NEOPLASIA, 3(3), 2001, pp. 255-263
Dose conformity of Gamma Knife radiosurgery and risk factors for complications
Authors: Nakamura, JL Verhey, LJ Smith, V Petti, PL Lamborn, KR Larson, DA Wara, WM McDermott, MW Sneed, PK
Citation: Jl. Nakamura et al., Dose conformity of Gamma Knife radiosurgery and risk factors for complications, INT J RAD O, 51(5), 2001, pp. 1313-1319
Relationship between pattern of enhancement and local control of brain metastases after radiosurgery
Authors: Goodman, KA Sneed, PK McDermott, MW Shiau, CY Lamborn, KR Chang, S Park, E Wara, WM Larson, DA
Citation: Ka. Goodman et al., Relationship between pattern of enhancement and local control of brain metastases after radiosurgery, INT J RAD O, 50(1), 2001, pp. 139-146
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome
Authors: Keles, GE Lamborn, KR Berger, MS
Citation: Ge. Keles et al., Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome, J NEUROSURG, 95(5), 2001, pp. 735-745
Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model
Authors: Kuriyama, N Kuriyama, H Julin, CM Lamborn, KR Israel, MA
Citation: N. Kuriyama et al., Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model, CANCER RES, 61(5), 2001, pp. 1805-1809
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients
Authors: Simmons, ML Lamborn, KR Takahashi, M Chen, PC Israel, MA Berger, MS Godfrey, T Nigro, J Prados, M Chang, S Barker, FG Aldape, K
Citation: Ml. Simmons et al., Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients, CANCER RES, 61(3), 2001, pp. 1122-1128
Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival
Authors: Kunwar, S Mohapatra, G Bollen, A Lamborn, KR Prados, M Feuerstein, BG
Citation: S. Kunwar et al., Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival, CANCER RES, 61(20), 2001, pp. 7683-7688
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
Authors: DeNardo, SJ Burke, PA Leigh, BR O'Donnell, RT Miers, LA Kroger, LA Goodman, SL Matzku, S Jonczyk, A Lamborn, KR DeNardo, GL
Citation: Sj. Denardo et al., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, CANC BIO R, 15(1), 2000, pp. 71-79
Meta-analysis: Methods, strengths, and weaknesses - The article reviewed
Authors: Lamborn, KR
Citation: Kr. Lamborn, Meta-analysis: Methods, strengths, and weaknesses - The article reviewed, ONCOLOGY-NY, 14(3), 2000, pp. 444
Efficacy and toxicity of radioimmunotherapy with Y-90-DOTA-Peptide-ChL6 for PC3-tumored mice
Authors: O'Donnell, RT DeNardo, SJ DeNardo, GL Miers, L Lamborn, KR Kukis, DL Meyers, FJ
Citation: Rt. O'Donnell et al., Efficacy and toxicity of radioimmunotherapy with Y-90-DOTA-Peptide-ChL6 for PC3-tumored mice, PROSTATE, 44(3), 2000, pp. 187-192
(67)Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl]-TETA Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma
Authors: O'Donnell, RT DeNardo, GL Kukis, DL Lamborn, KR Shen, S Yuan, AN Goldstein, DS Mirick, GR DeNardo, SJ
Citation: Rt. O'Donnell et al., (67)Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl]-TETA Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma, CLIN CANC R, 5(10), 1999, pp. 3330S-3336S
Radiation-induced DNA double-strand breaks and rejoining in malignant glioma cells
Authors: Ozawa, T Wang, J Lamborn, KR Deen, DF
Citation: T. Ozawa et al., Radiation-induced DNA double-strand breaks and rejoining in malignant glioma cells, INT J RAD B, 75(5), 1999, pp. 563-570
Radiosurgery for brain metastases: Is whole brain radiotherapy necessary?
Authors: Sneed, PK Lamborn, KR Forstner, JM McDermot, MW Chang, S Park, E Gutin, PH Phillips, TL Wara, WM Larson, DA
Citation: Pk. Sneed et al., Radiosurgery for brain metastases: Is whole brain radiotherapy necessary?, INT J RAD O, 43(3), 1999, pp. 549-558
Radiopotentiation of human brain tumor cells by sodium phenylacetate
Authors: Ozawa, T Lu, RM Hu, LJ Lamborn, KR Prados, MD Deen, DF
Citation: T. Ozawa et al., Radiopotentiation of human brain tumor cells by sodium phenylacetate, CANCER LETT, 142(2), 1999, pp. 139-146
Critical Lym-1 binding residues on polymorphic HLA-DR molecules
Authors: Rose, LM Deng, CT Scott, SL Xiong, CY Lamborn, KR Gumerlock, PH DeNardo, GL Meares, CF
Citation: Lm. Rose et al., Critical Lym-1 binding residues on polymorphic HLA-DR molecules, MOL IMMUNOL, 36(11-12), 1999, pp. 789-797
Factors affecting I-131-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia
Authors: DeNardo, GL DeNardo, SJ Shen, S DeNardo, DA Mirick, GR Macey, DJ Lamborn, KR
Citation: Gl. Denardo et al., Factors affecting I-131-Lym-1 pharmacokinetics and radiation dosimetry in patients with non-Hodgkin's lymphoma and chronic lymphocytic leukemia, J NUCL MED, 40(8), 1999, pp. 1317-1326
A clinical trial of radioimmunotherapy with Cu-67-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma
Authors: O'Donnell, RT DeNardo, GL Kukis, DL Lamborn, KR Shen, S Yuan, AN Goldstein, DS Carr, CE Mirick, GR DeNardo, SJ
Citation: Rt. O'Donnell et al., A clinical trial of radioimmunotherapy with Cu-67-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma, J NUCL MED, 40(12), 1999, pp. 2014-2020
Transsphenoidal microsurgical therapy of prolactinomas: Initial outcomes and long-term results
Authors: Tyrrell, JB Lamborn, KR Hannegan, LT Applebury, CB Wilson, CB
Citation: Jb. Tyrrell et al., Transsphenoidal microsurgical therapy of prolactinomas: Initial outcomes and long-term results, NEUROSURGER, 44(2), 1999, pp. 254-261
Toxicology of a boronated porphyrin in dogs
Authors: Tibbitts, J Fike, JR Lamborn, KR Bollen, AW Kahl, SB
Citation: J. Tibbitts et al., Toxicology of a boronated porphyrin in dogs, PHOTOCHEM P, 69(5), 1999, pp. 587-594
Long-term impairment of subependymal repopulation following damage by ionizing irradiation
Authors: Tada, E Yang, C Gobbel, GT Lamborn, KR Fike, JR
Citation: E. Tada et al., Long-term impairment of subependymal repopulation following damage by ionizing irradiation, EXP NEUROL, 160(1), 1999, pp. 66-77
Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors
Authors: Russo, C Pellarin, M Tingby, O Bollen, AW Lamborn, KR Mohapatra, G Collins, VP Feuerstein, BG
Citation: C. Russo et al., Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors, CANCER, 86(2), 1999, pp. 331-339
Final report on the University of California San Francisco experience withbromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients
Authors: Lamborn, KR Prados, MD Kaplan, SB Davis, RL
Citation: Kr. Lamborn et al., Final report on the University of California San Francisco experience withbromodeoxyuridine labeling index as a prognostic factor for the survival of glioma patients, CANCER, 85(4), 1999, pp. 925-935
Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma
Authors: Haslam, RHA Lamborn, KR Becker, LE Israel, MA
Citation: Rha. Haslam et al., Tumor cell apoptosis present at diagnosis may predict treatment outcome for patients with medulloblastoma, J PED H ONC, 20(6), 1998, pp. 520-527
Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol
Authors: Denardo, SJ Richman, CM Kukis, DL Shen, S Lamborn, KR Miers, LA Kroger, LA Perez, EA DeNardo, GL
Citation: Sj. Denardo et al., Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol, ANTICANC R, 18(6A), 1998, pp. 4011-4018
Risultati: 1-25 |